Balyasny Asset Management
CLCD

Balyasny Asset Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Balyasny Asset Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-184,000
Closed -$6.7M – 1906
2016
Q4 		$6.7M Buy
184,000
+76,500
+71% +$2.71M 0.04% 607
2016
Q3 		$4.1M Buy
+107,500
New +$1.59M 0.02% 531

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Balyasny Asset Management's CLCD Position: Q1 2017 in Review

Balyasny Asset Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 184,000 shares — an estimated $6.7M sold.

Balyasny Asset Management first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $6.7M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Balyasny Asset Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Balyasny Asset Management sold 184,000 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $6.7M.
  • Balyasny Asset Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • Balyasny Asset Management's CoLucid Pharmaceuticals, Inc. position peaked at $6.7M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Balyasny Asset Management's 13F filing for Q1 2017, filed 15 May 2017.